REFERENCES
1. Nair H, Simoes EA, Rudan I, Gessner BD, Azziz-Baumgartner E, Zhang
JSF, Feikin DR, Mackenzie GA, Moiisi JC, Roca A, et al. Global and
regional burden of hospital admissions for severe acute lower
respiratory infections in young children in 2010: a systematic analysis.
Lancet 2013; 381:1380-90.
2. Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE,
Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, et al.
Clinical practice guideline: the diagnosis, management, and prevention
of bronchiolitis. Pediatrics 2014; 134:e1474-502.
3. Dumas O, Mansbach JM, Jartti T, Hasegawa K, Sullivan AF, Piedra PA,
Camargo CA, Jr. A clustering approach to identify severe bronchiolitis
profiles in children. Thorax 2016; 71:712-8.
4. Dumas O, Hasegawa K, Mansbach JM, Sullivan AF, Piedra PA, Camargo CA,
Jr. Severe bronchiolitis profiles and risk of recurrent wheeze by age 3
years. J Allergy Clin Immunol 2019; 143:1371-9 e7.
5. Bønnelykke K, Vissing NH, Sevelsted A, Johnston SL, Bisgaard H.
Association between respiratory infections in early life and later
asthma is independent of virus type. J Allergy Clin Immunol 2015;
136:81-6. e4.
6. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, Sly
PD. Early-life respiratory viral infections, atopic sensitization, and
risk of subsequent development of persistent asthma. J Allergy Clin
Immunol 2007; 119:1105-10.
7. McCallum GB, Chatfield MD, Morris PS, Chang AB. Risk factors for
adverse outcomes of Indigenous infants hospitalized with bronchiolitis.
Pediatr Pulmonol 2016; 51:613-23.
8. Cunningham S, Nair H, Campbell H. Deciphering clinical phenotypes in
acute viral lower respiratory tract infection: Bronchiolitis is not an
island. Thorax 2016; 71:679-80
9. Chawes BL, Poorisrisak P, Johnston SL, Bisgaard H. Neonatal bronchial
hyperresponsiveness precedes acute severe viral bronchiolitis in
infants. J Allergy Clin Immunol 2012; 130:354-61 e3.
10. Welliver RC. Review of epidemiology and clinical risk factors for
severe respiratory syncytial virus (RSV) infection. J Pediatr 2003;
143:S112-7.
11. Bailey EJ, Maclennan C, Morris PS, Kruske SG, Brown N, Chang AB.
Risks of severity and readmission of Indigenous and non-Indigenous
children hospitalised for bronchiolitis. J Paediatr Child Health 2009;
45:593-7.
12. Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G,
Cullinan P, Custovic A, Ducharme FM, Fahy JV, et al. After asthma:
redefining airways diseases. Lancet 2018; 391:350-400.
13. Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis
and treatment. Lancet 2018; 392:866-79.
14. Balekian DS, Linnemann RW, Hasegawa K, Thadhani R, Camargo CA, Jr.
Cohort Study of Severe Bronchiolitis during Infancy and Risk of Asthma
by Age 5 Years. J Allergy Clin Immunol Pract 2017;5: 92-6.
15. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE,
Printz MC, Lee WM, Shult PA, Reisdorf E, et al. Wheezing rhinovirus
illnesses in early life predict asthma development in high-risk
children. Am J Respir Crit Care Med 2008; 178:667-72.
16. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM,
Wright AL, Martinez FD. Respiratory syncytial virus in early life and
risk of wheeze and allergy by age 13 years. Lancet 1999;354: 541-5.
17. Wright PF, Gruber WC, Peters M, Reed G, Zhu Y, Robinson F,
Coleman-Dockery S, Graham BS. Illness severity, viral shedding, and
antibody responses in infants hospitalized with bronchiolitis caused by
respiratory syncytial virus. J Infect Dis 2002; 185:1011-8.
18. Singleton RJ, Redding GJ, Lewis TC, Martinez P, Bulkow L, Morray B,
Peters H, Gove J, Jones C, Stamey D, et al. Sequelae of severe
respiratory syncytial virus infection in infancy and early childhood
among Alaska native children. Pediatrics 2003; 112:285-90.
19. McCallum GB, Morris PS, Chatfield MD, Maclennan C, White AV, Sloots
TP, Mackay IM, Chang AB. A single dose of azithromycin does not improve
clinical outcomes of children hospitalised with bronchiolitis: a
randomised, placebo-controlled trial. PloS One 2013; 8:e74316.
20. McCallum GB, Morris PS, Grimwood K, Maclennan C, White AV, Chatfield
MD, Sloots TP, Mackay IM, Smith-Vaughan H, McKay CC, et al. Three-weekly
doses of azithromycin for indigenous infants hospitalized with
bronchiolitis: a multicentre, randomized, placebo-controlled trial.
Front Pediatr 2015; 3:32.
21. McCallum GB, Morris PS, Wilson CC, Versteegh LA, Ward LM, Chatfield
MD, Chang AB. Severity scoring systems: are they internally valid,
reliable and predictive of oxygen use in children with acute
bronchiolitis? Pediatr Pulmonol 2013; 48:797-803.
22. Hare KM, Grimwood K, Leach AJ, Smith-Vaughan H, Torzillo PJ, Morris
PS, Chang AB. Respiratory bacterial pathogens in the nasopharynx and
lower airways of Australian indigenous children with bronchiectasis. J
Pediatr 2010; 157:1001-5.
23. Di Franco G. Multiple correspondence analysis: one only or several
techniques? Qual Quant 2016; 50:1299-315.
24. Sourial N, Wolfson C, Zhu B, Quail J, Fletcher J, Karunananthan S,
Bandeen-Roche K, Béland F, Bergman H. Correspondence analysis is a
useful tool to uncover the relationships among categorical variables. J
Clin Epidemiol 2010; 63:638-46.
25. Sclove SL. Application of model-selection criteria to some problems
in multivariate analysis. Psychometrika 1987; 52:333-43.
26. Dziak JJ, Coffman DL, Lanza ST, Li R. Sensitivity and specificity of
information criteria. Brief Bioinform 2020; 21:553-565.
27. Schwarz G. Estimating the dimension of a model. Ann Stat 1978; 6:
461-4.
28. Akaike H. Information theory and an extension of the maximum
likelihood principle. Selected papers of hirotugu akaike: Springer;
1998. p199-213.
29. Boeschoten L, Oberski DL, De Waal T, Vermunt JK. Updating Latent
Class Imputations with External Auxiliary Variables. Struct Equ Modeling
2018; 25:750-61.
30. Singleton RJ, Valery PC, Morris P, Byrnes CA, Grimwood K, Redding G,
Torzillo PJ, McCallum G, Chikoyak L, Mobberly C, et al. Indigenous
children from three countries with non-cystic fibrosis chronic
suppurative lung disease/bronchiectasis. Pediatr Pulmonol 2014;
49:189-200.
31. Smith-Vaughan H, Byun R, Nadkarni M, Jacques NA, Hunter N, Halpin S,
Morris PS, Leach AJ. Measuring nasal bacterial load and its association
with otitis media. BMC Ear Nose Throat Disord 2006; 6:10.
32. Usami S. Performance of information criteria for model selection in
a latent growth curve mixture model. JJSCS 2014; 27:17-48.
33. Wraith D, Wolfe R. Classifying patients by their characteristics and
clinical presentations; the use of latent class analysis. Respirology
2014; 19:1138-48.
34. Mansbach JM, Hasegawa K, Henke DM, Ajami NJ, Petrosino JF, Shaw CA,
Piedra PA, Sullivan AF, Espinola JA, Camargo CA, Jr. Respiratory
syncytial virus and rhinovirus severe bronchiolitis are associated with
distinct nasopharyngeal microbiota. J Allergy Clin Immunol 2016;
137:1909-13 e4.